{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "OPR",
      "openfda": {
        "pma_number": [
          "P170032"
        ],
        "registration_number": [
          "3013408612",
          "2029214",
          "3008307705",
          "3022418643",
          "3013556777",
          "2011171"
        ],
        "fei_number": [
          "1000220862",
          "3013408612",
          "3008307705",
          "3022418643",
          "3013556777",
          "2011171"
        ]
      },
      "review_panel": "NE",
      "medical_specialty": "",
      "device_name": "Intrasaccular Flow Disruption Device",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Unknown",
      "device_class": "3",
      "definition": "An intrasaccular flow disruption device is intended for use to treat wide-neck intracranial aneurysms in the neurovasculature through an endovascular approach.",
      "regulation_number": "",
      "implant_flag": "Y",
      "submission_type_id": "2"
    }
  ]
}